Using a mobile app to help manage uncontrolled type 2 diabetes
Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
This study is testing whether a mobile app can help people with uncontrolled type 2 diabetes learn to manage their condition better and make lasting lifestyle changes compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 65 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Reading Hospital and Medical Center Academic / other |
| Locations | 1 site (West Reading, Pennsylvania) |
| Trial ID | NCT05893927 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a mobile web application designed to educate patients with uncontrolled type 2 diabetes and assist them in making sustainable lifestyle changes. Participants will be divided into two groups: one using the app for educational content on diabetes management, while the other continues with standard care without the app. The study aims to assess the app's impact on clinical outcomes, such as HbA1c levels, and educational outcomes, including self-efficacy in diabetes management. The trial will also monitor changes in cardiometabolic risk factors like BMI and blood pressure.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a diagnosis of type 2 diabetes and an HbA1c level greater than 8.0.
Not a fit: Patients who are pregnant, incarcerated, lack access to a smartphone, or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve diabetes management and health outcomes for patients with uncontrolled type 2 diabetes.
How similar studies have performed: Other studies have shown promising results with mobile health applications for diabetes management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of Type 2 Diabetes with HA1c \>8.0 * Current patients of the Family Healthcare Center, Reading Hospital Tower health. Exclusion Criteria: * Identified special populations (pregnancy or individuals currently incarcerated) * Patients without access to their own smart phone * Any patient who is unable to provide their own informed consent to participate in the study
Where this trial is running
West Reading, Pennsylvania
- Reading Hospital, an affiliate of Tower Health — West Reading, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Luis A Murillo, MD, MPH — Reading Hospital Tower Health
- Study coordinator: Mary E Alderfer, MSN
- Email: mary.alderfer@towerhealth.org
- Phone: 484-628-8360
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.